Monashee Investment Management »

Eliem Therapeutics shares owned by Monashee Investment Management

Quarter-by-quarter ownership of Eliem Therapeutics (ELYM) shares owned by Monashee Investment Management from 13F filings

Historical chart of Monashee Investment Management investment in Eliem Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Eliem Therapeutics held by Monashee Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Eliem Therapeutics by Monashee Investment Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $1.2M 230k 5.09
2022-03-31 $1.9M 227k 8.39
2021-12-31 $3.1M 300k 10.46
2021-09-30 $5.5M 305k 17.98

More positions owned by Monashee Investment Management

Ishares Tr Core S&p500 Etf (IVV)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Ishares Tr Core Msci Eafe (IEFA)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)
Ishares Core Msci Emkt (IEMG)
Ishares Tr Core S&p Ttl Stk (ITOT)
Vanguard Index Fds Total Stk Mkt (VTI)
Casella Waste Sys Cl A (CWST)
Aercap Holdings Nv SHS (AER)
Viking Holdings Ord Shs (VIK)
American Healthcare Reit Com Shs (AHR)
Lineage
Sable Offshore Corp Com Shs (SOC)
Newmont Mining Corporation (NEM)

View all positions for Monashee Investment Management

Top funds holding Eliem Therapeutics

RA Capital Management
Deep Track Capital
Samsara BioCapital
Henderson Group
Boxer Capital
BlackRock
Affinity Asset Advisors
Driehaus Capital Management
Geode Capital Management
Nan Fung Group Holdings
BlackRock
Vanguard Group
Northern Trust
Dr. Jeffrey R. Jay, M.D.
Monashee Investment Management

View all funds holding Eliem Therapeutics